Literature DB >> 15821011

Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy.

Michael Christ1, Theresia Klima, Wolfram Grimm, Hans-Helge Mueller, Bernhard Maisch.   

Abstract

AIMS: Previous studies indicate that low cholesterol levels are associated with adverse prognosis in heart failure patients, because elevated lipoprotein levels may negate bacterial endotoxin load induced by gastrointestinal congestion. METHODS AND
RESULTS: We examined the prognostic significance of lipid levels in a cohort of 422 patients with idiopathic dilated cardiomyopathy (iDCM) [50+/-12 years, 342 males, 80 females, left ventricular ejection fraction (LV-EF): 31.6+/-10.6%]. During 42 months of follow-up, 86 patients (20.3%) died or received a heart transplant. In univariate Cox regression analysis, reduced LV-EF, high New York Heart Association (NYHA) class, and increased LV end-diastolic diameter (LVEDD) were strong risk factors associated with that endpoint, whereas decreased total cholesterol, HDL-cholesterol, and apoprotein I levels were identified as weak risk predictors. After step-wise multivariable analysis, only LVEDD, NYHA class, and LV-EF emerged as parameters independently contributing to the model predicting risk for death or heart transplantation (P<0.05). Cholesterol levels were positively associated with LV-EF and negatively associated with LVEDD (P<0.05). Circulating sCD14 levels, a marker of endotoxin exposure, were related to cholesterol levels (P<0.05) and LV-EF (P<0.05).
CONCLUSION: Decreased cholesterol levels do not independently predict adverse prognosis in patients with iDCM. Our findings indicate that low cholesterol levels are dependent on the severity of cardiac disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15821011     DOI: 10.1093/eurheartj/ehi195

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  11 in total

Review 1.  Low-density lipoprotein in the setting of congestive heart failure: is lower really better?

Authors:  Tamara Horwich
Journal:  Curr Atheroscler Rep       Date:  2009-09       Impact factor: 5.113

2.  Anti-oxidative and cholesterol efflux capacities of high-density lipoprotein are reduced in ischaemic cardiomyopathy.

Authors:  Parin J Patel; Amit V Khera; Robert L Wilensky; Daniel J Rader
Journal:  Eur J Heart Fail       Date:  2013-05-24       Impact factor: 15.534

Review 3.  Statins in the treatment of chronic heart failure: a systematic review.

Authors:  Pim van der Harst; Adriaan A Voors; Wiek H van Gilst; Michael Böhm; Dirk J van Veldhuisen
Journal:  PLoS Med       Date:  2006-08       Impact factor: 11.069

4.  Relationship between lipids levels and right ventricular volume overload in congestive heart failure.

Authors:  Ying Chen; Xiao-Mei He; Hong Meng; Qing-Zhen Zhao; Yu-Zhi Zhen; Li Tian; Le Wang; Li-Shuang Ji; Guo-Ping Ma; Yu Tian; Gang Liu; Zhen-Guo Ji; Kun-Shen Liu; Chao Liu
Journal:  J Geriatr Cardiol       Date:  2014-09       Impact factor: 3.327

5.  Metrics of High-Density Lipoprotein Function and Hospital Mortality in Acute Heart Failure Patients.

Authors:  Ines Potočnjak; Vesna Degoricija; Matias Trbušić; Sanda Dokoza Terešak; Bojana Radulović; Gudrun Pregartner; Andrea Berghold; Beate Tiran; Gunther Marsche; Saša Frank
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

Review 6.  Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence.

Authors:  Matthew M Y Lee; Naveed Sattar; John J V McMurray; Chris J Packard
Journal:  Curr Atheroscler Rep       Date:  2019-07-27       Impact factor: 5.113

7.  CHOLESTEROL AND CHLORIDE IN ACUTE HEART FAILURE.

Authors:  Bojana Radulović; Ines Potočnjak; Sanda Dokoza Terešak; Matias Trbušić; Nada Vrkić; Azra Huršidić Radulović; Neven Starčević; Milan Milošević; Vesna Degoricija; Saša Frank
Journal:  Acta Clin Croat       Date:  2019-06       Impact factor: 0.780

8.  Association between hyperlipidemia and mortality after incident acute myocardial infarction or acute decompensated heart failure: a propensity score matched cohort study and a meta-analysis.

Authors:  Mohammed Yousufuddin; Paul Y Takahashi; Brittny Major; Eimad Ahmmad; Hossam Al-Zubi; Jessica Peters; Taylor Doyle; Kelsey Jensen; Ruaa Y Al Ward; Umesh Sharma; Ashok Seshadri; Zhen Wang; Vinaya Simha; M Hassan Murad
Journal:  BMJ Open       Date:  2019-12-15       Impact factor: 2.692

9.  Polyunsaturated fatty acids supplementation impairs anti-oxidant high-density lipoprotein function in heart failure.

Authors:  Raphael Wurm; Lore Schrutka; Alexandra Hammer; Deddo Moertl; Rudolf Berger; Noemi Pavo; Irene M Lang; Georg Goliasch; Martin Huelsmann; Klaus Distelmaier
Journal:  Eur J Clin Invest       Date:  2018-08-01       Impact factor: 4.686

10.  High density lipoprotein cholesterol / C reactive protein ratio in heart failure with preserved ejection fraction.

Authors:  Masamichi Yano; Masami Nishino; Kohei Ukita; Akito Kawamura; Hitoshi Nakamura; Yutaka Matsuhiro; Koji Yasumoto; Masaki Tsuda; Naotaka Okamoto; Akihiro Tanaka; Yasuharu Matsunaga-Lee; Yasuyuki Egami; Ryu Shutta; Jun Tanouchi; Takahisa Yamada; Yoshio Yasumura; Shunsuke Tamaki; Takaharu Hayashi; Akito Nakagawa; Yusuke Nakagawa; Shinichiro Suna; Daisaku Nakatani; Shungo Hikoso; Yasushi Sakata
Journal:  ESC Heart Fail       Date:  2021-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.